# Fimasartan (BR-A-657) Multiple Oral Dose in Healthy Subjects

> **NCT01289899** · PHASE1 · COMPLETED · sponsor: **Boryung Pharmaceutical Co., Ltd** · enrollment: 16 (actual)

## Conditions studied

- Essential Hypertension

## Interventions

- **DRUG:** BR-A-657

## Key facts

- **NCT ID:** NCT01289899
- **Lead sponsor:** Boryung Pharmaceutical Co., Ltd
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-01
- **Primary completion:** 2004-02
- **Final completion:** 2004-02
- **Target enrollment:** 16 (ACTUAL)
- **Last updated:** 2011-02-04

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01289899

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01289899, "Fimasartan (BR-A-657) Multiple Oral Dose in Healthy Subjects". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01289899. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*